World's Best Scientists 2026 revealed!
Kazuto Nishio

Kazuto Nishio

D-Index & Metrics

Medicine

D-Index
97
Citations
29220
World Ranking
9412
National Ranking
252

Overview

Kazuto Nishio is affiliated with Kindai University in Japan. Their research focuses primarily on medicine, with substantial contributions to biochemistry, genetics, and molecular biology. Within these broad fields, Nishio's work extensively covers oncology, pulmonary and respiratory medicine, cancer research, molecular biology, and pathology and forensic medicine.

The scientist has contributed significantly to topics related to lung cancer treatments and mutations, cancer genomics and diagnostics, cancer immunotherapy and biomarkers, colorectal cancer treatments and studies, lung cancer research studies, lung cancer diagnosis and treatment, and prostate cancer treatment and research.

Some of Nishio's recent papers include:

  • "Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site" (2020, JAMA Oncology)
  • "KRAS Inhibitor Resistance in MET -Amplified KRAS G12C Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling Mechanisms" (2021, Clinical Cancer Research)
  • "Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors" (2020, The Oncologist)
  • "Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)" (2020, International Journal of Clinical Oncology)
  • "Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody" (2021, Liver Cancer)

Nishio frequently collaborates with a group of co-authors, including Kazuko Sakai, Kazuhiko Nakagawa, Hidetoshi Hayashi, Marco A. De Velasco, and Hirotsugu Uemura.

The scientist's work is published regularly in several established venues. Frequent publication venues for Nishio include Cancer Research, Annals of Oncology, Journal of Clinical Oncology, JTO Clinical and Research Reports, and Cancer Science.

Best Publications

  • Novel Cisplatin-Incorporated Polymeric Micelles Can Eradicate Solid Tumors in Mice

    Nobuhiro Nishiyama;Souichiro Okazaki;Horacio Cabral;Masaki Miyamoto

  • Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab

    Kimio Yonesaka;Kreshnik Zejnullahu;Isamu Okamoto;Taroh Satoh

  • LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both

    Nobuyuki Katakami;Shinji Atagi;Koichi Goto;Toyoaki Hida

  • Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer

    Hideharu Kimura;Kazuo Kasahara;Makoto Kawaishi;Hideo Kunitoh

  • METALLOTHIONEIN CONTENT CORRELATES WITH THE SENSITIVITY OF HUMAN SMALL CELL LUNG CANCER CELL LINES TO CISPLATIN

    Kazuo Kasahara;Yasuhiro Fujiwara;Yasuhiro Fujiwara;Kazuto Nishio;Tohru Ohmori

  • Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor.

    Hideharu Kimura;Kazuko Sakai;Tokuzo Arao;Tatsu Shimoyama

  • Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer

    Koichi Goto;Yukito Ichinose;Yuichiro Ohe;Nobuyuki Yamamoto

  • Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)

    H Kimura;M Suminoe;K Kasahara;T Sone

  • Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment.

    K. Haratani;H. Hayashi;T. Tanaka;H. Kaneda

  • Apoptosis of Lung Cancer Cells Caused by Some Anti-cancer Agents (MMC, CPT-11, ADM) is Inhibited by BCL-2

    Tohru Ohmori;Eckhard R. Podack;Kazuto Nishio;Minako Takahashi

  • FGFR2 gene amplification and clinicopathological features in gastric cancer

    K Matsumoto;T Arao;T Hamaguchi;Y Shimada

  • FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.

    Hiroyasu Kaneda;Tokuzo Arao;Kaoru Tanaka;Daisuke Tamura

  • Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth.

    Michihiro Hirama;Fumiyuki Takahashi;Fumiyuki Takahashi;Kazuhisa Takahashi;Shigeru Akutagawa

  • Thymidylate Synthase as a Determinant of Pemetrexed Sensitivity in Non-Small Cell Lung Cancer

    K Takezawa;I Okamoto;W Okamoto;M Takeda

  • AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor

    Masayuki Takeda;Tokuzo Arao;Hideyuki Yokote;Teruo Komatsu

  • Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors

    Kazuhiko Yamada;Noboru Yamamoto;Yasuhide Yamada;Hiroshi Nokihara

  • FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer

    K. Tamura;C. Shimizu;T. Hojo;S. Akashi-Tanaka

  • Synergism between Cisplatin and Topoisomerase I Inhibitors, NB-506 and SN-38, in Human Small Cell Lung Cancer Cells

    Minoru Fukuda;Kazuto Nishio;Fumihiko Kanzawa;Hayato Ogasawara

  • Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells.

    H Kurokawa;K Nishio;H Fukumoto;A Tomonari

  • Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells

    Y Basaki;F Hosoi;F Hosoi;Y Oda;A Fotovati

Frequent Co-Authors

Kazuhiko Nakagawa
Kazuhiko Nakagawa Kindai University
Isamu Okamoto
Isamu Okamoto Kyushu University
Nagahiro Saijo
Nagahiro Saijo AstraZeneca (United Kingdom)
Tomohide Tamura
Tomohide Tamura St. Luke's International Hospital
Tetsuya Mitsudomi
Tetsuya Mitsudomi Kindai University
Yuichiro Ohe
Yuichiro Ohe National Cancer Centre
Narikazu Boku
Narikazu Boku St. Marianna University School of Medicine
Masahiro Fukuoka
Masahiro Fukuoka Kindai University
Masatoshi Kudo
Masatoshi Kudo Kindai University
Akihiko Ito
Akihiko Ito Kindai University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers beyond a traditional MD, there are a number of related online degrees and career pathways to consider. Online learning options can offer greater flexibility and affordability while still leading to rewarding jobs in medicine and healthcare.

Many choose to start with medical billing and coding classes online. These programs offer entry into the administrative side of healthcare and require less time and investment than a full degree.

For aspiring nurses, it’s important to ask how much does online nursing school cost before enrolling. Affordable nursing programs are available and can help you avoid excessive debt as you enter the profession.

Those wishing to advance their nursing credentials may look into cheapest nurse practitioner programs, which provide greater autonomy and earning potential. For those aiming even higher, cheapest dnp programs online can unlock advanced practice and leadership opportunities.

Exploring these online pathways can be a smart way to enter or progress in the medical and healthcare fields while managing costs.

Best Scientists Citing Kazuto Nishio

Trending Scientists

Recently Published Articles